4.59 USD
↘ 0.23 (4.77%)LIVE (AS OF 03:21 PM EDT)
Insight Molecular Diagnostics Inc. Common Stock
IMDXNASDAQ • USD
Market: OPEN
Insight Molecular Diagnostics Inc. Common Stock (IMDX) is currently trading at $4.59. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (447.5%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 15, 2026.
Open?$4.82
High?$4.93
Low?$4.56
Prev. Close?$4.82
Volume?86.7K
Avg. Volume?274.1K
VWAP?$4.72
Rel. Volume?0.32x
Bid / Ask
Bid?$4.58 × 100
Ask?$5.32 × 100
Spread?$0.74
Midpoint?$4.95
Valuation & Ratios
Market Cap?155.6M
Shares Out?32.3M
Float?25.5M
Float %?78.9%
P/E Ratio?N/A
P/B Ratio?-14.56
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
Employees
58
Market Cap
155.6M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Website
Listed
2015-12-30
Address
2 INTERNATIONAL PLAZA DR., SUITE 510
NASHVILLE, TN 37217
Phone: 949-409-7600
NASHVILLE, TN 37217
Phone: 949-409-7600
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-16.09Distress
Confidence?25%Very Low
Short InterestModerate
Short % of Float?3.95%Low
Short Interest?1.0M
Days to Cover?4.3
Free Float25.5M
Avg Daily Volume234.4K
Settlement Date2026-06-30
Financial Health
Current Ratio?2.48Strong
Quick Ratio?2.45Strong
Cash Ratio?2.35Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-14.56CHEAP▾
S&P97
P/S?79.86HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.4CHEAP▾
S&P97
EV/Sales?65.39HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?447.5%STRONG▾
Peers50
S&P97
ROA?-118.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27456000
Enterprise Value?$127.4M
Fundamentals ratios updated end of day